Millions of Americans rely on over-the-counter medicines known as OTCs to treat conditions such as allergies, sleep issues, or pain. Following the COVID-19 pandemic, OTCs have become an even more essential part of the treatment toolbox as people increasingly look for cost effective ways to take greater control of their health. Today, we're going to take a look at the value created by OTC medicines to the US healthcare system as we walk through some of the top findings from CHPA's latest OTC value study,
Note: IRI has since changed its name to Circana
With special guests:
Kristin Hornberger EVP, Practice Leader Consumer Healthcare, Circana
Mindy Albuck, Principal and Team Lead, Client Insights, Circana
David Spangler, Senior Vice President, Legal, Government Affairs & Policy, CHPA
Hosted by:
Anita Brikman, Senior Vice President, Communications & Public Affairs, CHPA; and Executive Director, CHPA Educational Foundation
Podden och tillhörande omslagsbild på den här sidan tillhör
CHPA. Innehållet i podden är skapat av CHPA och inte av,
eller tillsammans med, Poddtoppen.